Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Junyuan Jerry Wang Insider Profile
4 Followers
Junyuan Jerry Wang, CEO, ANHEART THERAPEUTICS LTD., Director at Nuvation Bio, holds 1.93M shares in Nuvation Bio (Ticker: NUVB).
Junyuan Jerry Wang has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Junyuan Jerry Wang's holdings
Insider Roles
CEO, ANHEART THERAPEUTICS LTD., Director
Roles that Junyuan Jerry Wang holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Junyuan Jerry Wang
Junyuan Jerry Wang's Trading History
List of latest transactions for each holding click on a transaction to see Junyuan Jerry Wang's performance on stock
You May Also Like
Junyuan Jerry Wang insider profile FAQ
What is the percentage of profitable transactions made by Junyuan Jerry Wang?
The percentage of profitable transactions made by Junyuan Jerry Wang is ―.
What is the average return per transaction made by Junyuan Jerry Wang?
The average return per transaction made by Junyuan Jerry Wang is ―.
What stocks does Junyuan Jerry Wang hold?
Junyuan Jerry Wang holds: NUVB stocks.
What was Junyuan Jerry Wang’s latest transaction?
Junyuan Jerry Wang latest transaction was an Uninformative Buy of ―.
What was Junyuan Jerry Wang's most profitable transaction?
Junyuan Jerry Wang’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Junyuan Jerry Wang's role in Nuvation Bio?
Junyuan Jerry Wang's role in Nuvation Bio is CEO, ANHEART THERAPEUTICS LTD., Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.